The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Methylomes variation to predict exemestane resistance in advanced breast cancer.
 
Xiao-Ran Liu
No Relationships to Disclose
 
Ru-Yan Zhang
No Relationships to Disclose
 
Hao Gong
Employment - M3 Genomics, Inc.
 
Hope S. Rugo
Honoraria - Genomic Health
Consulting or Advisory Role - Amgen
Speakers' Bureau - Genomic Health
Research Funding - Eisai (Inst); Genentech (Inst); GTx (Inst); Immunomedics (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech
 
Jian Tie
No Relationships to Disclose
 
Lingbo Chen
Leadership - M3 Genomics, Inc.
 
Yuan Fu
Leadership - M3 Genomics, Inc.
Stock and Other Ownership Interests - M3 Genomics, Inc.
 
Jianwei Che
Leadership - M3 Genomics, Inc.
Stock and Other Ownership Interests - M3 Genomics, Inc.
 
Bin Shao
No Relationships to Disclose
 
Wei-yao Kong
No Relationships to Disclose
 
Guo-hong Song
No Relationships to Disclose
 
Han-fang Jiang
No Relationships to Disclose
 
Guo-bing Xu
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose